| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2003-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_533b654bbd11ee0f2e5b920618509705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dea7bf2328791b17272d628bc641fce |
| publicationDate |
2004-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004132731-A1 |
| titleOfInvention |
Novel combination |
| abstract |
Combinations comprising a) an inhibitor of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) and b) an angiotensin II receptor antagonist are useful for treating hypertension. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009174871-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007129415-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007203211-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007051007-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9289802-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007051007-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010237530-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2324886-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005165169-A1 |
| priorityDate |
2002-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |